Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week

J Verbeeck, M De Backer, J Verwerft… - Journal of the American …, 2023 - jacc.org
A time-to-first-event composite endpoint analysis has well-known shortcomings in evaluating
a treatment effect in cardiovascular clinical trials. It does not fully describe the clinical benefit …
被引用次数：3 相关文章

[引用][C] Generalized Pairwise Comparisons to Assess Treatment Effects

J Verbeeck, M De Backer, J Verwerft… - 2023 - publications.goettingen-research …

Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week

J Verbeeck, M De Backer, J Verwerft… - Journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
A time-to-first-event composite endpoint analysis has well-known shortcomings in evaluating
a treatment effect in cardiovascular clinical trials. It does not fully describe the clinical benefit …

Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week.

J Verbeeck, M De Backer, J Verwerft… - Journal of the …, 2023 - europepmc.org
A time-to-first-event composite endpoint analysis has well-known shortcomings in evaluating
a treatment effect in cardiovascular clinical trials. It does not fully describe the clinical benefit …

Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week

J Verbeeck, M De Backer, J Verwerft… - Journal of the American …, 2023 - Elsevier
A time-to-first-event composite endpoint analysis has well-known shortcomings in evaluating
a treatment effect in cardiovascular clinical trials. It does not fully describe the clinical benefit …

Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week

J VERBEECK, M De Backer, J VERWERFT… - 2023 - documentserver.uhasselt.be
A time-to-first-event composite endpoint analysis has well-known shortcomings in evaluating
a treatment effect in cardiovascular clinical trials. It does not fully describe the clinical benefit …